Insider Transactions Reported by 9 Insiders of Sorrento Therapeutics, Inc.

Symbol
SRNE on OTC
Location
San Diego, CA

There are no Buy or Sell transactions made by insiders since 18 Mar 2025

Sorrento Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Henry Ji President, CEO and Chairman of the Board of Directors, Director $6,901,212 17 Mar 2023
Robin L. Smith Director $188,635 03 Sep 2021
Kim Janda Director $2,408 31 Dec 2021
Jaisim Shah Director 30 Aug 2021
Yue Alexander Wu Director 30 Aug 2021
Tammy Reilly Director 18 May 2022
Elizabeth Czerepak EVP & Chief Financial Officer 18 May 2022
Dorman Followwill Director 30 Aug 2021
David Lemus Director 30 Aug 2021

Recent Insider Transactions by Companies or Individuals for Sorrento Therapeutics, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
No insider transactions were found in the last 12 months for this issuer.
* An asterisk sign (*) next to the price indicates that the price is likely invalid.